Influence of copper on early development: Prenatal and postnatal considerations

BioFactors

Volumn 36, Issue 2, 2010, Pages 136-152

  Uriu Adams, Janet Y ^a   Scherr, Rachel E ^a   Lanoue, Louise ^a   Keen, Carl L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Copper deficiency; Embryo; Nitric oxide; Pregnancy

Indexed keywords

BINDING PROTEIN; COPPER; COPPER BINDING PROTEIN; COPPER TRANSPORTER 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C; DITHIOCARBAMIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IRON; MEMBRANE PROTEIN; MENKES PROTEIN; NITRIC OXIDE; PENICILLAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN LYSINE 6 OXIDASE; SCLEROPROTEIN; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC;

ANEMIA; ANGIOGENESIS; APOPTOSIS; ARTHROGRYPOSIS; BEHAVIOR; BONE DISEASE; BRAIN; CARDIOMYOPATHY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COPPER BLOOD LEVEL; COPPER DEFICIENCY; COPPER METABOLISM; CORPUS CALLOSUM AGENESIS; CUTIS LAXA; DIET SUPPLEMENTATION; DIETARY INTAKE; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE MUTATION; HAIR DISEASE; HEART DEVELOPMENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTHYROIDISM; INGUINAL HERNIA; INTRAUTERINE CONTRACEPTIVE DEVICE; IRON METABOLISM; LACTATION; MATERNAL NUTRITION; MENKES SYNDROME; MICROGNATHIA; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUTROPENIA; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; POSTNATAL DEVELOPMENT; PREGNANCY; PREMATURITY; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; SIDE EFFECT; SIGNAL TRANSDUCTION; TERATOGENICITY; VASCULARIZATION; VERY LOW BIRTH WEIGHT; WEIGHT GAIN; WILSON DISEASE; YOLK SAC;

ANIMALS; COPPER; FEMALE; HUMANS; NITRIC OXIDE; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 77951136381     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.85     Document Type: Review

References (204)

1. MACDP. (2007) 40th Anniversary edition surveillance report. Birth Defects Res. Part A: Clin. Mol. Teratol. 79, 66-186.
2. Keen, C. L., Clegg, M. S., Hanna, L. A., Lanoue, L., Rogers, J. M., Daston, G. P., Oteiza, P., and Uriu-Adams, J. Y. (2003) The plausibility of micronutrient deficiencies being a significant contributing factor to the occurrence of pregnancy complications. J. Nutr. 133, 1597S-1605S. (Pubitemid 36548665)
3. Turski, M. L. and Thiele, D. J. (2009) New roles for copper metabolism in cell proliferation, signaling, and disease. J. Biol. Chem. 284, 717-721.
4. Bennetts, H. W. and Chapman, F. E. (1937) Copper deficiency in sheep in Western Australia: a preliminary account of the aetiology of enzootic ataxia of lambs and anemia of the ewe. Aust. Vet. J. 13, 138-149.
5. Innes, J. R. M. (1939) Swayback: a demyelinating disease of lambs with affinities to Schilder's encephalitis and its prevention by copper. J. Neurol. Psychiatry 2, 323-334.
6. Hurley, L. S. (1981) Teratogenic aspects of manganese, zinc, and copper nutrition. Physiol. Rev. 61, 249-295.
7. Hamza, I., Faisst, A., Prohaska, J., Chen, J., Gruss, P., and Gitlin, J. D. (2001) The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc. Natl. Acad. Sci. USA 98, 6848-6852.
8. Lee, J., Prohaska, J. R., and Thiele, D. J. (2001) Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc. Natl. Acad. Sci. USA 98, 6842-6847.
9. Kuo, Y. M., Zhou, B., Cosco, D., and Gitschier, J. (2001) The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc. Natl. Acad. Sci. USA 98, 6836-6841.
10. Takahashi, Y., Kako, K., Kashiwabara, S., Takehara, A., Inada, Y., Arai, H., Nakada, K., Kodama, H., Hayashi, J., Baba, T., and Munekata, E. (2002) Mammalian copper chaperone cox17p has an essential role in activation of cytochrome C oxidase and embryonic development. Mol. Cell. Biol. 22, 7614-7621.
11. Andreini, C., Banci, L., Bertini, I., and Rosato, A. (2008) Occurrence of copper proteins through the three domains of life: a bioinformatic approach. J. Proteome Res. 7, 209-216. (Pubitemid 351171133)
12. Keen, C. L., Uriu-Hare, J. Y., Hawk, S. N., Jankowski, M. A., Daston, G. P., Kwik-Uribe, C. L., and Rucker, R. B. (1998) Effect of copper deficiency on prenatal development and pregnancy outcome. Am. J. Clin. Nutr. 67, 1003S-1011S.
13. Kendall, N. R., Marsters, P., Guo, L., Scaramuzzi, R. J., and Campbell, B. K. (2006) Effect of copper and thiomolybdates on bovine theca cell differentiation in vitro. J. Endocrinol. 189, 455-463. (Pubitemid 43919223)
14. Champagne, C. M., Bogle, M. L., McGee, B. B., Yadrick, K., Allen, H. R., Kramer, T. R., Simpson, P., Gossett, J., and Weber, J. (2004) Dietary intake in the lower Mississippi delta region: results from the Foods of our Delta Study. J. Am. Diet. Assoc. 104, 199-207.
15. Champagne, C. M., Casey, P. H., Connell, C. L., Stuff, J. E., Gossett, J. M., Harsha, D. W., McCabe-Sellers, B., Robbins, J. M., Simpson, P. M., Weber, J. L., and Bogle, M. L. (2007) Poverty and food intake in rural America: diet quality is lower in food insecure adults in the Mississippi Delta. J. Am. Diet. Assoc. 107, 1886-1894.
16. Carmichael, S. L., Shaw, G. M., Selvin, S., and Schaffer, D. M. (2003) Diet quality and risk of neural tube defects. Med. Hypotheses 60, 351-355. (Pubitemid 36237963)
17. Stern, B. R., Solioz, M., Krewski, D., Aggett, P., Aw, T. C., Baker, S., Crump, K., Dourson, M., Haber, L., Hertzberg, R., Keen, C., Meek, B., Rudenko, L., Schoeny, R., Slob, W., and Starr, T. (2007) Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships. J. Toxicol. Environ. Health B Crit. Rev. 10, 157-222.
18. Barone, A., Ebesh, O., Harper, R. G., and Wapnir, R. A. (1998) Placental copper transport in rats: effects of elevated dietary zinc on fetal copper, iron and metallothionein. J. Nutr. 128, 1037-1041. (Pubitemid 28280206)
19. Botash, A. S., Nasca, J., Dubowy, R., Weinberger, H. L., and Oliphant, M. (1992) Zinc-induced copper deficiency in an infant. Am. J. Dis. Child. 146, 709-711.
20. Willis, M. S., Monaghan, S. A., Miller, M. L., McKenna, R. W., Perkins, W. D., Levinson, B. S., Bhushan, V., and Kroft, S. H. (2005) Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am. J. Clin. Pathol. 123, 125-131.
21. Irving, J. A., Mattman, A., Lockitch, G., Farrell, K., and Wadsworth, L. D. (2003) Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation. Can. Med. Assoc. J. 169, 129-131.
22. Pastel, L. C. and Ross, J. M. (2007) Too much of a good thing. Am. J. Med. 120, 316-318.
23. Nations, S. P., Boyer, P. J., Love, L. A., Burritt, M. F., Butz, J. A., Wolfe, G. I., Hynan, L. S., Reisch, J., and Trivedi, J. R. (2008) Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 71, 639-643.
24. Institute of Medicine. (1990) In Nutrition During Pregnancy: Part I: Weight Gain, Part II: Nutrient Supplements (Subcommittee on Nutritional Status and Weight Gain During Pregnancy, ed.). National Academy Press, Washington, DC.
25. Ziaei, S., Norrozi, M., Faghihzadeh, S., and Jafarbegloo, E. (2007) A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥ 13.2 g/dl. B.J.O.G. 114, 684-688. (Pubitemid 46788644)
26. Ziaei, S., Janghorban, R., Shariatdoust, S., and Faghihzadeh, S. (2008) The effects of iron supplementation on serum copper and zinc levels in pregnant women with high-normal hemoglobin. Int. J. Gynaecol. Obstet. 100, 133-135.
27. Domellof, M., Dewey, K. G., Cohen, R. J., Lonnerdal, B., and Hernell, O. (2005) Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants. Acta Paediatr. 94, 1578-1582. (Pubitemid 41754311)
28. Lind, T., Seswandhana, R., Persson, L. A., and Lonnerdal, B. (2008) Iron supplementation of iron-replete Indonesian infants is associated with reduced weight-for-age. Acta Paediatr. 97, 770-775.
29. Fields, M., Lewis, C. G., Beal, T., and Scholfield, D. (1990) Copper deficiency in pregnancy: effect on maternal and fetal polyol metabolites. Metabolism 39, 531-537. (Pubitemid 20156321)
30. Keen, C. L., Lonnerdal, B., Hurley, L. S. (1982) Teratogenic effects of copper deficiency and excess. In: Sorenson JRJ, editor. Inflammatory diseases and copper. Clifton, New Jersey: Humana Press, Inc.
31. Carey, J. C., Martinez, L., Balken, E., Leen-Mitchell, M., and Robertson, J. (2009) Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines. Birth Defects Res. A Clin. Mol. Teratol. 85, 63-68.
32. Pinter, R., Hogge, W. A., and McPherson, E. (2004) Infant with severe penicillamine embryopathy born to a woman with Wilson disease. Am. J. Med. Genet. A 128, 294-298.
33. Martinez-Frias, M. L., Rodriguez-Pinilla, E., Bermejo, E., and Blanco, M. (1998) Prenatal exposure to penicillamine and oral clefts: case report. Am. J. Med. Genet. 76, 274-275.
34. Hanukoglu, A., Curiel, B., Berkowitz, D., Levine, A., Sack, J., and Lorberboym, M. (2008) Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. J. Pediatr. 153, 864-866.
35. Cooper, G. J., Phillips, A. R., Choong, S. Y., Leonard, B. L., Crossman, D. J., Brunton, D. H., Saafi, L., Dissanayake, A. M., Cowan, B. R., Young, A. A., Occleshaw, C. J., Chan, Y. K., Leahy, F. E., Keogh, G. F., Gamble, G. D., Allen, G. R., Pope, A. J., Boyd, P. D., Poppitt, S. D., Borg, T. K., Doughty, R. N., and Baker, J. R. (2004) Regeneration of the heart in diabetes by selective copper chelation. Diabetes 53, 2501-2508.
36. Brewer, G. J. (2005) Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer. Curr. Cancer Drug Targets 5, 195-202.
37. van Boxtel, A. L., Kamstra, J. H., Fluitsma, D. M., and Legler, E. J. Dithiocarbamates are teratogenic to developing zebrafish through inhibition of lysyl oxidase activity. Toxicol. Appl. Pharmacol (Epub ahead of print).
38. Molnar, J., Fong, K. S., He, Q. P., Hayashi, K., Kim, Y., Fong, S. F., Fogelgren, B., Szauter, K. M., Mink, M., and Csiszar, K. (2003) Structural and functional diversity of lysyl oxidase and the LOX-like proteins. Biochim. Biophys. Acta 1647, 220-224.
39. Rucker, R. B., Kosonen, T., Clegg, M. S., Mitchell, A. E., Rucker, B. R., Uriu-Hare, J. Y., and Keen, C. L. (1998) Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am. J. Clin. Nutr. 67, 996S-1002S.
40. Goodman, B. P., Bosch, E. P., Ross, M. A., Hoffman-Snyder, C., Dodick, D. D., and Smith, B. E. (2008) Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy. J. Neurol. Neurosurg. Psychiatry. 80, 524-527.
41. Kumar, N. (2006) Copper deficiency myelopathy (human swayback). Mayo Clin. Proc. 81, 1371-1384.
42. Aigner, E., Theurl, I., Haufe, H., Seifert, M., Hohla, F., Scharinger, L., Stickel, F., Mourlane, F., Weiss, G., and Datz, C. (2008) Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology 135, 680-688.
43. Henri-Bhargava, A., Melmed, C., Glikstein, R., and Schipper, H. M. (2008) Neurologic impairment due to vitamin E and copper deficiencies in celiac disease. Neurology 71, 860-861.
44. Juhasz-Pocsine, K., Rudnicki, S. A., Archer, R. L., and Harik, S. I. (2007) Neurologic complications of gastric bypass surgery for morbid obesity. Neurology 68, 1843-1850. (Pubitemid 46791400)
45. Weihl, C. C. and Lopate, G. (2006) Motor neuron disease associated with copper deficiency. Muscle Nerve. 34, 789-793 (Pubitemid 44877566)
46. Fong, T., Vij, R., Vijayan, A., DiPersio, J., and Blinder, M. (2007) Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome. Haematologica 92, 1429-1430. (Pubitemid 350144165)
47. Harvey, L. J. and McArdle, H. J. (2008) Biomarkers of copper status: a brief update. Br. J. Nutr. 99 (Suppl 3), S10-S13.
48. Cordano, A. (1998) Clinical manifestations of nutritional copper deficiency in infants and children. Am. J. Clin. Nutr. 67, 1012S-1016S.
49. March of Dimes. Available at: www.marchofdimes.com/peristats. Accessed January 29, 2010.
50. National Center for Health Statistics. Available at: http://www.cdc.gov/ NCHS/. Accessed January 29, 2010.
51. Koo, W. W., Succop, P., and Hambidge, K. M. (1991) Sequential concentrations of copper and ceruloplasmin in serum from preterm infants with rickets and fractures. Clin. Chem. 37, 556-559.
52. Nassi, N., Ponziani, V., Becatti, M., Galvan, P., and Donzelli, G. (2009) Anti-oxidant enzymes and related elements in term and preterm new-borns. Pediatr. Int. 51, 183-187.
53. L'Abbe, M. R. and Friel, J. K. (1992) Copper status of very low birth weight infants during the first 12 months of infancy. Pediatr. Res. 32, 183-188.
54. Barclay, S. M., Aggett, P. J., Lloyd, D. J., and Duffty, P. (1991) Reduced erythrocyte superoxide dismutase activity in low birth weight infants given iron supplements. Pediatr. Res. 29, 297-301.
55. Angotti, L. B., Post, G. R., Robinson, N. S., Lewis, J. A., Hudspeth, M. P., and Lazarchick, J. (2008) Pancytopenia with myelodysplasia due to copper deficiency. Pediatr. Blood Cancer 51, 693-695.
56. Haschke, F., Ziegler, E. E., Edwards, B. B., and Fomon, S. J. (1986) Effect of iron fortification of infant formula on trace mineral absorption. J. Pediatr. Gastroenterol. Nutr. 5, 768-773.
57. Institute of Medicine. (2002) Copper. In Dietary Reference Intakes: Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (Food and Nutrition Board, ed.). pp. 224-257, National Academy Press, Washington, DC.
58. Keen, C. L. and Uriu-Adams, J. Y. (2006) Assessment of zinc, copper and magnesium status: current approaches and promising new directions. In Mineral Requirements for Military Personnel (Institute of Medicine, ed.). pp. 304-315, The National Academies Press, Washington, DC.
59. Walter, R. M., Jr., Uriu-Hare, J. Y., Olin, K. L., Oster, M. H., Anawalt, B. D., Critchfield, J. W., and Keen, C. L. (1991) Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 14, 1050-1056.
60. Brown, K. H., Lanata, C. F., Yuen, M. L., Peerson, J. M., Butron, B., and Lonnerdal, B. (1993) Potential magnitude of the misclassification of a population's trace element status due to infection: example from a survey of young Peruvian children. Am. J. Clin. Nutr. 58, 549-554.
61. Bo, S., Durazzo, M., Gambino, R., Berutti, C., Milanesio, N., Caropreso, A., Gentile, L., Cassader, M., Cavallo-Perin, P., and Pagano, G. (2008) Associations of dietary and serum copper with inflammation, oxidative stress, and metabolic variables in adults. J. Nutr. 138, 305-310. (Pubitemid 351213644)
62. Beckers-Trapp, M. E., Lanoue, L., Keen, C. L., Rucker, R. B., and Uriu-Adams, J. Y. (2006) Abnormal development and increased 3-nitrotyrosine in copper-deficient mouse embryos. Free Radic. Biol. Med. 40, 35-44.
63. Yang, S. J., Keen, C. L., Lanoue, L., Rucker, R. B., and Uriu-Adams, J. Y. (2007) Low nitric oxide: a key factor underlying copper-deficiency teratogenicity. Free Radic. Biol. Med. 43, 1639-1648.
64. Hawk, S. N., Uriu-Hare, J. Y., Daston, G. P., Jankowski, M. A., Kwik-Uribe, C., Rucker, R. B., and Keen, C. L. (1998) Rat embryos cultured under copper-deficient conditions develop abnormally and are characterized by an impaired oxidant defense system. Teratology 57, 310-320. (Pubitemid 28362548)
65. Sarricolea, M. L., Villa-Elizaga, I., and Lopez, J. (1993) Respiratory distress syndrome in copper deficiency: an experimental model developed in rats. Biol. Neonate 63, 14-25. (Pubitemid 23063971)
66. Arce, D. S. and Keen, C. L. (1992) Reversible and persistent consequences of copper deficiency in developing mice. Reprod. Toxicol. 6, 211-221.
67. Alliende Gonzales, F., Villa Elizaga, I., and Antillon Klussmann, F. (1991) Copper deficiency and persistence of the ductus arteriosus. Dev. Pharmacol. Ther. 17, 172-179.
68. Percival, S. S. (1998) Copper and immunity. Am. J. Clin. Nutr. 67, 1064S-1068S.
69. Prohaska, J. R. and Bailey, W. R. (1994) Regional specificity in alterations of rat brain copper and catecholamines following perinatal copper deficiency. J. Neurochem. 63, 1551-1557.
70. Hall, G. A. and Howell, J. M. (1969) The effect of copper deficiency on reproduction in the female rat. Br. J. Nutr. 23, 41-45.
71. Penland, J. G. and Prohaska, J. R. (2004) Abnormal motor function persists following recovery from perinatal copper deficiency in rats. J. Nutr. 134, 1984-1988.
72. Everson, G. J., Tsai, H. C., and Wang, T. I. (1967) Copper deficiency in the guinea pig. J. Nutr. 93, 533-540.
73. Carlton, W. W. and Kelly, W. A. (1969) Neural lesions in the offspring of female rats fed a copper-deficient diet. J. Nutr. 97, 42-52.
74. Faye, B., Grillet, C., Tessema, A., and Kamil, M. (1991) Copper deficiency in ruminants in the Rift Valley of East Africa. Trop. Anim. Health Prod. 23, 172-180.
75. Joseph, J., Alleyne, T., and Adogwa, A. (2007) Marginally low copper causes lesions of the midbrain in animal models: the implications for man. West Indian Med. J. 56, 481-486. (Pubitemid 351552366)
76. Wiener, G. and Field, A. C. (1969) Copper concentrations in the liver and blood of sheep of different breeds in relation to swayback history. J. Comp. Pathol. 79, 7-14.
77. Prohaska, J. R. and Wells, W. W. (1975) Copper deficiency in the developing rat brain: evidence for abnormal mitochondria. J. Neurochem. 25, 221-228.
78. Gybina, A. A., Tkac, I., and Prohaska, J. R. (2009) Copper deficiency alters the neurochemical profile of developing rat brain. Nutr. Neurosci. 12, 114-122.
79. Prohaska, J. R., Gybina, A. A., Broderius, M., and Brokate, B. (2005) Peptidylglycine-alpha-amidating monooxygenase activity and protein are lower in copper-deficient rats and suckling copper-deficient mice. Arch. Biochem. Biophys. 434, 212-220.
80. Madsen, E. and Gitlin, J. D. (2007) Copper and iron disorders of the brain. Annu. Rev. Neurosci. 30, 317-337.
81. Ashkenazi, A., Levin, S., Djaldetti, M., Fishel, E., and Benvenisti, D. (1973) The syndrome of neonatal copper deficiency. Pediatrics 52, 525-533.
82. Zucconi, G. G., Cipriani, S., Scattoni, R., Balgkouranidou, I., Hawkins, D. P., and Ragnarsdottir, K. V. (2007) Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders. Neuropathol. Appl. Neurobiol. 33, 212-225.
83. Pyatskowit, J. W. and Prohaska, J. R. (2007) Rodent brain and heart catecholamine levels are altered by different models of copper deficiency. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 145, 275-281.
84. Prohaska, J. R., Bailey, W. R., and Lear, P. M. (1995) Copper deficiency alters rat peptidylglycine alpha-amidating monooxygenase activity. J. Nutr. 125, 1447-1454.
85. Birkaya, B. and Aletta, J. M. (2004) NGF promotes copper accumulation required for optimum neurite outgrowth and protein methylation. J. Neurobiol. 63, 49-61. (Pubitemid 40344288)
86. Rossi, L., Marchese, E., Lombardo, M. F., Rotilio, G., and Ciriolo, M. R. (2001) Increased susceptibility of copper-deficient neuroblastoma cells to oxidative stress-mediated apoptosis. Free Radic. Biol. Med. 30, 1177-1187.
87. Schlief, M. L., Craig, A. M., and Gitlin, J. D. (2005) NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J. Neurosci. 25, 239-246. (Pubitemid 40110786)
88. Vlachova, V., Zemkova, H., and Vyklicky, L., Jr. (1996) Copper modulation of NMDA responses in mouse and rat cultured hippocampal neurons. Eur. J. Neurosci. 8, 2257-2264.
89. Schlief, M. L., West, T., Craig, A. M., Holtzman, D. M., and Gitlin, J. D. (2006) Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity. Proc. Natl. Acad. Sci. USA 103, 14919-14924.
90. Bousquet-Moore, D., Prohaska, J. R., Nillni, E. A., Czyzyk, T., Wetsel, W. C., Mains, R. E., and Eipper, B. A. (2010) Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction. Neurobiol. Dis. 37, 130-140.
91. Bennetts, H. W., Beck, A. B., and Harley, R. (1948) The pathogenesis of falling disease: studies of copper deficiency in cattle. Aust. Vet. J. 24, 237-244.
92. Kelly, W. A., Kesterson, J. W., and Carlton, W. W. (1974) Myocardial lesions in the offspring of female rats fed a copper deficient diet. Exp. Mol. Pathol. 20, 40-56.
93. Medeiros, D. M. and Wildman, R. E. (1997) Newer findings on a unified perspective of copper restriction and cardiomyopathy. Proc. Soc. Exp. Biol. Med. 215, 299-313.
94. Wildman, R. E., Hopkins, R., Failla, M. L., and Medeiros, D. M. (1995) Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat. Proc. Soc. Exp. Biol. Med. 210, 43-49.
95. Klevay, L. M. and Viestenz, K. E. (1981) Abnormal electrocardiograms in rats deficient in copper. Am. J. Physiol. 240, H185-H189.
96. Saari, J. T., Wold, L. E., Duan, J., Ren, J., Carlson, H. L., Bode, A. M., Lentsch, A. B., Zeng, H., and Schuschke, D. A. (2007) Cardiac nitric oxide synthases are elevated in dietary copper deficiency. J. Nutr. Biochem. 18, 443-448.
97. Kang, Y. J., Zhou, Z. X., Wu, H., Wang, G. W., Saari, J. T., and Klein, J. B. (2000) Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab. Invest. 80, 745-757.
98. Johnson, W. T. and Newman, S. M., Jr. (2007) Hearts in adult offspring of copper-deficient dams exhibit decreased cytochrome c oxidase activity, increased mitochondrial hydrogen peroxide generation and enhanced formation of intracellular residual bodies. J. Nutr. Biochem. 18, 97-104.
99. Salviati, L., Hernandez-Rosa, E., Walker, W. F., Sacconi, S., DiMauro, S., Schon, E. A., and Davidson, M. M. (2002) Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations. Biochem. J. 363, 321-327. (Pubitemid 34415768)
100. Johnson, W. T. and Anderson, C. M. (2008) Cardiac cytochrome C oxidase activity and contents of subunits 1 and 4 are altered in offspring by low prenatal copper intake by rat dams. J. Nutr. 138, 1269-1273.
101. Gybina, A. A. and Prohaska, J. R. (2003) Increased rat brain cytochrome c correlates with degree of perinatal copper deficiency rather than apoptosis. J. Nutr. 133, 3361-3368.
102. Medeiros, D. M., Bagby, D., Ovecka, G., and McCormick, R. (1991) Myofibrillar, mitochondrial and valvular morphological alterations in cardiac hypertrophy among copper-deficient rats. J. Nutr. 121, 815-824.
103. Farquharson, C. and Robins, S. P. (1991) Immunolocalization of collagen types I, III and IV, elastin and fibronectin within the heart of normal and copper-deficient rats. J. Comp. Pathol. 104, 245-255.
104. Kang, Y. J., Wu, H., and Saari, J. T. (2000) Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart. Proc. Soc. Exp. Biol. Med. 223, 282-287.
105. Elsherif, L., Wang, L., Saari, J. T., and Kang, Y. J. (2004) Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice. J. Nutr. 134, 855-860. (Pubitemid 38456254)
106. Zhou, Z., Johnson, W. T., and Kang, Y. J. (2009) Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes. J. Nutr. Biochem. 20, 621-628.
107. Jiang, Y., Reynolds, C., Xiao, C., Feng, W., Zhou, Z., Rodriguez, W., Tyagi, S. C., Eaton, J. W., Saari, J. T., and Kang, Y. J. (2007) Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J. Exp. Med. 204, 657-666.
108. Zhou, Y., Jiang, Y., and Kang, Y. J. (2007) Copper inhibition of hydrogen peroxide-induced hypertrophy in embryonic rat cardiac H9c2 cells. Exp. Biol. Med. (Maywood) 232, 385-389.
109. Wagner, M. and Siddiqui, M. A. (2007) Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation. Exp. Biol. Med. (Maywood) 232, 866-880.
110. Chen, Y., Saari, J. T., and Kang, Y. J. (1994) Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radic. Biol. Med. 17, 529-536.
111. Kang, Y. J., Jiang, Y., and Saari, J. T. (2007) Changes in copper and zinc status and response to dietary copper deficiency in metallothionein- overexpressing transgenic mouse heart. J. Nutr. Biochem. 18, 714-718.
112. Li, Y., Wang, L., Schuschke, D. A., Zhou, Z., Saari, J. T., and Kang, Y. J. (2005) Marginal dietary copper restriction induces cardiomyopathy in rats. J. Nutr. 135, 2130-2136. (Pubitemid 41298377)
113. Hunsaker, H. A., Morita, M., and Allen, K. G. (1984) Marginal copper deficiency in rats. Aortal morphology of elastin and cholesterol values in first-generation adult males. Atherosclerosis 51, 1-19.
114. Seidel, K. E., Failla, M. L., and Rosebrough, R. W. (1991) Cardiac catecholamine metabolism in copper-deficient rats. J. Nutr. 121, 474-483.
115. Elsherif, L., Ortines, R. V., Saari, J. T., and Kang, Y. J. (2003) Congestive heart failure in copper-deficient mice. Exp. Biol. Med. (Maywood) 228, 811-817.
116. Vadlamudi, R. K., McCormick, R. J., Medeiros, D. M., Vossoughi, J., and Failla, M. L. (1993) Copper deficiency alters collagen types and covalent cross-linking in swine myocardium and cardiac valves. Am. J. Physiol. 264, H2154-H2161.
117. Zeng, H., Saari, J. T., and Dahlen, G. M. (2006) Copper deficiency increases fibulin-5 (DANCE/EVEC) but decreases cytochrome C oxidase VIb subunit expression in rat heart. J. Inorg. Biochem. 100, 186-191.
118. Medeiros, D. M., Jiang, Y., Klaahsen, D., and Lin, D. (2009) Mitochondrial and sarcoplasmic protein changes in hearts from copper-deficient rats: up-regulation of PGC-1alpha transcript and protein as a cause for mitochondrial biogenesis in copper deficiency. J. Nutr. Biochem. 20, 823-830.
119. Davidson, J., Medeiros, D. M., and Hamlin, R. L. (1992) Cardiac ultra-structural and electrophysiological abnormalities in postweanling copper-restricted and copper-repleted rats in the absence of hypertrophy. J. Nutr. 122, 1566-1575.
120. Kaler, S. G. (1998) Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. Am. J. Clin. Nutr. 67, 1029S-1034S.
121. Yang, S. J., Uriu-Adams, J. Y., Keen, C. L., Rucker, R. B., and Lanoue, L. (2006) Effects of copper deficiency on mouse yolk sac vasculature and expression of angiogenic mediators. Birth Defects Res. B. Dev. Reprod. Toxicol. 77, 445-454.
122. O'Dell, B. L., Hardwick, B. C., and Reynolds, G. (1961) Mineral deficiencies of milk and congenital malformations in the rat. J. Nutr. 73, 151-157.
123. Mendelsohn, B. A., Yin, C., Johnson, S. L., Wilm, T. P., Solnica-Krezel, L., and Gitlin, J. D. (2006) Atp7a determines a hierarchy of copper metabolism essential for notochord development. Cell Metab. 4, 155-162. (Pubitemid 44138717)
124. Finney, L., Vogt, S., Fukai, T., and Glesne, D. (2009) Copper and angio-genesis: unravelling a relationship key to cancer progression. Clin. Exp. Pharmacol. Physiol. 36, 88-94.
125. Camphausen, K., Sproull, M., Tantama, S., Sankineni, S., Scott, T., Menard, C., Coleman, C. N., and Brechbiel, M. W. (2003) Evaluation of copper chelation agents as anti-angiogenic therapy. Bioorg. Med. Chem. 11, 4287-4293.
126. Sen, C. K., Khanna, S., Venojarvi, M., Trikha, P., Ellison, E. C., Hunt, T. K., and Roy, S. (2002) Copper-induced vascular endothelial growth factor expression and wound healing. Am. J. Physiol. Heart Circ. Physiol. 282, H1821-H1827.
127. Soncin, F., Guitton, J. D., Cartwright, T., and Badet, J. (1997) Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. Biochem. Biophys. Res. Commun. 236, 604-610.
128. Baxter, J. H. and van Wyk, J. J. (1953) A bone disorder associated with copper deficiency. I. Gross morphological, roentgenological, and chemical observations. Bull. Johns Hopkins Hosp. 93, 1-23.
129. Allen, T. M., Manoli, A., II, and LaMont, R. L. (1982) Skeletal changes associated with copper deficiency. Clin. Orthop. Relat. Res. 168, 206-210.
130. Dubick, M. A., Keen, C. L., and Rucker, R. B. (1985) Elastin metabolism during perinatal lung development in the copper-deficient rat. Exp. Lung Res. 8, 227-241.
131. Abdel-Mageed, A. B., Welti, R., Oehme, F. W., and Pickrell, J. A. (1994) Perinatal hypocuprosis affects synthesis and composition of neonatal lung collagen, elastin, and surfactant. Am. J. Physiol. 267, L679-L685.
132. Maritz, G. S., Matthews, H. L., and Aalbers, J. (2000) Maternal copper supplementation protects the neonatal rat lung against the adverse effects of maternal nicotine exposure. Reprod. Fertil. Dev. 12, 97-103.
133. 2+ on relaxations to the nitrergic neurotransmitter, NO and S-nitrosothiols in the rat gastric fundus. Br. J. Pharmacol. 119, 990-996.
134. Cordano, A., Baertl, J. M., and Graham, G. G. (1964) Copper deficiency in infancy. Pediatrics 34, 324-336.
135. Yuen, P., Lin, H. J., and Hutchinson, J. H. (1979) Copper deficiency in a low birthweight infant. Arch. Dis. Child 54, 553-555.
136. Sutton, A. M., Harvie, A., Cockburn, F., Farquharson, J., and Logan, R. W. (1985) Copper deficiency in the preterm infant of very low birth-weight. Four cases and a reference range for plasma copper. Arch. Dis. Child 60, 644-651.
137. Hart, E. B., Steenbock, H., Waddell, J., and Elvehjem, C. A. (1928) Iron nutrition. VII. Copper is a supplement to iron for hemoglobin building in rat. J. Biol. Chem. 77, 797-812.
138. Reeves, P. G. and DeMars, L. C. (2004) Copper deficiency reduces iron absorption and biological half-life in male rats. J. Nutr. 134, 1953-1957.
139. George, E. L., Baldwin, H. S., and Hynes, R. O. (1997) Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood 90, 3073-3081.
140. Hill, K. E. and Davidson, J. M. (1986) Induction of increased collagen and elastin biosynthesis in copper-deficient pig aorta. Arteriosclerosis 6, 98-104. (Pubitemid 16154617)
141. Geach, T. J. and Dale, L. (2005) Members of the lysyl oxidase family are expressed during the development of the frog Xenopus laevis. Differentiation 73, 414-424. (Pubitemid 43920088)
142. Hornstra, I. K., Birge, S., Starcher, B., Bailey, A. J., Mecham, R. P., and Shapiro, S. D. (2003) Lysyl oxidase is required for vascular and diaphragmatic development in mice. J. Biol. Chem. 278, 14387-14393.
143. Maki, J. M., Rasanen, J., Tikkanen, H., Sormunen, R., Makikallio, K., Kivirikko, K. I., and Soininen, R. (2002) Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106, 2503-2509. (Pubitemid 35278809)
144. Maki, J. M., Sormunen, R., Lippo, S., Kaarteenaho-Wiik, R., Soininen, R., and Myllyharju, J. (2005) Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am. J. Pathol. 167, 927-936.
145. Rucker, R. B., Romero-Chapman, N., Wong, T., Lee, J., Steinberg, F. M., McGee, C., Clegg, M. S., Reiser, K., Kosonen, T., Uriu-Hare, J. Y., Murphy, J., and Keen, C. L. (1996) Modulation of lysyl oxidase by dietary copper in rats. J. Nutr. 126, 51-60. (Pubitemid 26030633)
146. Lutsenko, S., LeShane, E. S., and Shinde, U. (2007) Biochemical basis of regulation of human copper-transporting ATPases. Arch. Biochem. Biophys. 463, 134-148.
147. Mototani, Y., Miyoshi, I., Okamura, T., Moriya, T., Meng, Y., Yuan Pei, X., Kameo, S., and Kasai, N. (2006) Phenotypic and genetic characterization of the Atp7a(Mo-Tohm) mottled mouse: a new murine model of Menkes disease. Genomics 87, 191-199. (Pubitemid 43117439)
148. Flick, B. and Klug, S. (2006) Whole embryo culture: an important tool in developmental toxicology today. Curr. Pharm. Des. 12, 1467-1488.
149. Hawk, S. N., Lanoue, L., Keen, C. L., Kwik-Uribe, C. L., Rucker, R. B., and Uriu-Adams, J. Y. (2003) Copper-deficient rat embryos are characterized by low superoxide dismutase activity and elevated superoxide anions. Biol. Reprod. 68, 896-903.
150. Uriu-Adams, J. Y. and Keen, C. L. (2005) Copper, oxidative stress, and human health. Mol. Aspects Med. 26, 268-298.
151. Wells, P. G., McCallum, G. P., Chen, C. S., Henderson, J. T., Lee, C. J., Perstin, J., Preston, T. J., Wiley, M. J., and Wong, A. W. (2009) Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol. Sci. 108, 4-18.
152. Pacher, P., Beckman, J. S., and Liaudet, L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
153. Freixes, M., Rodriguez, A., Dalfo, E., and Ferrer, I. (2006) Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol. Aging 27, 1807-1815. (Pubitemid 44572578)
154. Rossi, L., Arciello, M., Capo, C., and Rotilio, G. (2006) Copper imbalance and oxidative stress in neurodegeneration. Ital. J. Biochem. 55, 212-221.
155. Mount, P. F., Kemp, B. E., and Power, D. A. (2007) Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J. Mol. Cell. Cardiol. 42, 271-279.
156. Nath, A. K., Enciso, J., Kuniyasu, M., Hao, X. Y., Madri, J. A., and Pinter, E. (2004) Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development 131, 2485-2496. (Pubitemid 38877654)
157. Fantel, A. G. and Person, R. E. (2002) Further evidence for the role of free radicals in the limb teratogenicity of L-NAME. Teratology 66, 24-32.
158. Gandley, R. E., Tyurin, V. A., Huang, W., Arroyo, A., Daftary, A., Harger, G., Jiang, J., Pitt, B., Taylor, R. N., Hubel, C. A., and Kagan, V. E. (2005) S-nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: effects in pregnancy and preeclampsia plasma. Hypertension 45, 21-27. (Pubitemid 40066408)
159. Didion, S. P., Ryan, M. J., Didion, L. A., Fegan, P. E., Sigmund, C. D., and Faraci, F. M. (2002) Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ. Res. 91, 938-944.
160. Lynch, S. M., Frei, B., Morrow, J. D., Roberts, L. J., II, Xu, A., Jackson, T., Reyna, R., Klevay, L. M., Vita, J. A., and Keaney, J. F., Jr. (1997) Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler. Thromb. Vasc. Biol. 17, 2975-2981.
161. Omar, H. A., Cherry, P. D., Mortelliti, M. P., Burke-Wolin, T., and
162. Falcone, J. C., Lominadze, D., Johnson, W. T., and Schuschke, D. A. (2008) Endothelial cell-derived nitric oxide mobilization is attenuated in copper-deficient rats. Appl. Physiol. Nutr. Metab. 33, 1073-1078.
163. Gibson, A. and Lilley, E. (1997) Superoxide anions, free-radical scavengers, and nitrergic neurotransmission. Gen. Pharmacol. 28, 489-493.
164. Schulz, R., Rassaf, T., Massion, P. B., Kelm, M., and Balligand, J. L. (2005) Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacol. Ther. 108, 225-256.
165. Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., and Michel, T. (1993) Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90, 347-351.
166. Bloch, W., Fleischmann, B. K., Lorke, D. E., Andressen, C., Hops, B., Hescheler, J., and Addicks, K. (1999) Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc. Res. 43, 675-684.
167. Zhao, X., Lu, X., and Feng, Q. (2002) Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 283, H2371-H2378.
168. Feng, Q., Song, W., Lu, X., Hamilton, J. A., Lei, M., Peng, T., and Yee, S. P. (2002) Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106, 873-879.
169. Watanabe, M., Choudhry, A., Berlan, M., Singal, A., Siwik, E., Mohr, S., and Fisher, S. A. (1998) Developmental remodeling and shortening of the cardiac outflow tract involves myocyte programmed cell death. Development 125, 3809-3820. (Pubitemid 28488356)
170. Jablonka-Shariff, A. and Olson, L. M. (1998) The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 139, 2944-2954. (Pubitemid 28512407)
171. Scherrer-Crosbie, M., Ullrich, R., Bloch, K. D., Nakajima, H., Nasseri, B., Aretz, H. T., Lindsey, M. L., Vancon, A. C., Huang, P. L., Lee, R. T., Zapol, W. M., and Picard, M. H. (2001) Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104, 1286-1291. (Pubitemid 32848119)
172. Fantel, A. G., Stamps, L. D., Tran, T. T., Mackler, B., Person, R. E., and Nekahi, N. (1999) Role of free radicals in the limb teratogenicity of L-NAME (NG-Nitro-L-Arginine Methyl Ester): a new mechanistic model of vascular disruption. Teratology 60, 151-160. (Pubitemid 29429919)
173. Shiva, S., Wang, X., Ringwood, L. A., Xu, X., Yuditskaya, S., Annavajjhala, V., Miyajima, H., Hogg, N., Harris, Z. L., and Gladwin, M. T. (2006) Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat. Chem. Biol. 2, 486-493.
174. Lee, J., Prohaska, J. R., Dagenais, S. L., Glover, T. W., and Thiele, D. J. (2000) Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant. Gene 254, 87-96.
175. Hua, H., Georgiev, O., Schaffner, W., and Steiger, D. (2009) Human copper transporter Ctr1 is functional in Drosophila, revealing a high degree of conservation between mammals and insects. J. Biol. Inorg. Chem. 15, 107-113.
176. Haremaki, T., Fraser, S. T., Kuo, Y. M., Baron, M. H., and Weinstein, D. C. (2007) Vertebrate Ctr1 coordinates morphogenesis and progenitor cell fate and regulates embryonic stem cell differentiation. Proc. Natl. Acad. Sci. USA 104, 12029-12034.
177. Mackenzie, N. C., Brito, M., Reyes, A. E., and Allende, M. L. (2004) Cloning, expression pattern and essentiality of the high-affinity copper transporter 1 (ctr1) gene in zebrafish. Gene 328, 113-120. (Pubitemid 38352887)
178. Murohara, T., Horowitz, J. R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A., and Isner, J. M. (1998) Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97, 99-107. (Pubitemid 28036160)
179. van der Zee, R., Murohara, T., Luo, Z., Zollmann, F., Passeri, J., Lekutat, C., and Isner, J. M. (1997) Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95, 1030-1037. (Pubitemid 27091550)
180. Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C. O., Buerk, D. G., Huang, P. L., and Jain, R. K. (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. USA 98, 2604-2609.
181. Jozkowicz, A., Cooke, J. P., Guevara, I., Huk, I., Funovics, P., Pachinger, O., Weidinger, F., and Dulak, J. (2001) Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc. Res. 51, 773-783.
182. Dulak, J., Jozkowicz, A., Dembinska-Kiec, A., Guevara, I., Zdzienicka, A., Zmudzinska-Grochot, D., Florek, I., Wojtowicz, A., Szuba, A., and Cooke, J. P. (2000) Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20, 659-666.
183. Papapetropoulos, A., Garcia-Cardena, G., Madri, J. A., and Sessa, W. C. (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100, 3131-3139.
184. Benoit, H., Jordan, M., Wagner, H., and Wagner, P. D. (1999) Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression. J. Appl. Physiol. 86, 1513-1518.
185. Vulpe, C. D., Kuo, Y. M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., and Anderson, G. J. (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21, 195-199.
186. Chen, H., Huang, G., Su, T., Gao, H., Attieh, Z. K., McKie, A. T., Anderson, G. J., and Vulpe, C. D. (2006) Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J. Nutr. 136, 1236-1241.
187. Reeves, P. G. and Demars, L. C. (2005) Repletion of copper-deficient rats with dietary copper restores duodenal hephaestin protein and iron absorption. Exp. Biol. Med. (Maywood) 230, 320-325.
188. Auclair, S., Feillet-Coudray, C., Coudray, C., Schneider, S., Muckenthaler, M. U., and Mazur, A. (2006) Mild copper deficiency alters gene expression of proteins involved in iron metabolism. Blood Cells Mol. Dis. 36, 15-20.
189. Andersen, H. S., Gambling, L., Holtrop, G., and McArdle, H. J. (2007) Effect of dietary copper deficiency on iron metabolism in the pregnant rat. Br. J. Nutr. 97, 239-246.
190. Pyatskowit, J. W. and Prohaska, J. R. (2008) Iron injection restores brain iron and hemoglobin deficits in perinatal copper-deficient rats. J. Nutr. 138, 1880-1886.
191. Haddad, D. S., Al-Alousi, L. A., and Kantarjian, A. H. (1991) The effect of copper loading on pregnant rats and their offspring. Funct. Dev. Morphol. 1, 17-22.
192. Golub, M. S., ed. (2006) Minerals, Fertility, and Reproductive Toxicity. Taylor & Francis, Boca Raton, FL.
193. Ferm, V. H. and Hanlon, D. P. (1974) Toxicity of copper salts in hamster embryonic development. Biol. Reprod. 11, 97-101.
194. Murawski, M., Bydlon, G., Sawicka-Kapusta, K., Wierzchos, E., Zakrzewska, M., Wlodarczyk, S., Molik, E., and Zieba, D. (2006) The effect of long term exposure to copper on physiological condition and reproduction of sheep. Reprod. Biol. 6 (Suppl 1), 201-206.
195. Johnson, A., Carew, E., and Sloman, K. A. (2007) The effects of copper on the morphological and functional development of zebrafish embryos. Aquat. Toxicol. 84, 431-438.
196. Lewis, S. S. and Keller, S. J. (2009) Identification of copper-responsive genes in an early life stage of the fathead minnow Pimephales promelas. Ecotoxicology 18, 281-292.
197. Toaff, R., Toaff, M. E., Peyser, M. R., and Streifler, M. (1977) Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case. Obstet. Gynecol. Surv. 32, 497-507.
198. Oga, M., Matsui, N., Anai, T., Yoshimatsu, J., Inoue, I., and Miyakawa, I. (1993) Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Am. J. Obstet. Gynecol. 169, 196-198.
199. ESHRE Capri Workshop Group. (2008) Intrauterine devices and intrauterine systems. Hum. Reprod. Update 14, 197-208.
200. Weissmann-Brenner, A., Lerner, A., and Peleg, D. (2007) Transverse limb reduction and intrauterine device: case report and review of the literature. Eur. J. Contracept. Reprod. Health Care 12, 294-297.
201. Tatum, H. J., Schmidt, F. H., and Jain, A. K. (1976) Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device. Am. J. Obstet. Gynecol. 126, 869-879.
202. Barash, A., Shoham, Z., Borenstein, R., and Nebel, L. (1990) Development of human embryos in the presence of a copper intrauterine device. Gynecol. Obstet. Invest. 29, 203-206.
203. Chang, C. C. and Tatum, H. J. (1973) Absence of teratogenicity of intrauterine copper wire in rats, hamsters and rabbits. Contraception 7, 413-434.
204. Araya, M., Koletzko, B., and Uauy, R. (2003) Copper deficiency and excess in infancy: developing a research agenda. J. Pediatr. Gastroenterol. Nutr. 37, 422-429.